Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|March 13, 2025
Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signalingNikos Koundouros, Michal J Nagiec, Nayah Bullen, et al.
Cancer Investigation|September 26, 2014
Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancerKevin Kalinsky, Emerson A Lim, Eleni Andreopoulou, et al.
Scientific Reports|November 16, 2021
Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancerTheofano Orfanelli, Spyridon Giannopoulos, Eleni Zografos, et al.
AJNR. American Journal of Neuroradiology|March 26, 2026
Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain MetastasesEzzat Elmoujarkach, Arman Sharbatdaran, Letizia Pontolillo, et al.
The Lancet. Oncology|March 2, 2010
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trialsNicolai Juul, Zoltan Szallasi, Aron C Eklund, et al.
Cell Reports|January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast CancerShira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Breast Cancer Research and Treatment|January 13, 2022
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancerGenevieve A Fasano, Solange Bayard, Yalei Chen, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
NPJ Breast Cancer|August 24, 2021
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancerYing L Liu, Cecilie Liv Bager, Nicholas Willumsen, et al.
Breast Cancer Research and Treatment|June 7, 2014
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancerYifan Tu, Dawn L Hershman, Kapil Bhalla, et al.
Pageof 5